Author:
Al-Azemi M.,Labib N.S.,Motawy M.M.M.,Temmim L.,Moussa M.A.A.,Omu A.E.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures;Geburtshilfe und Frauenheilkunde;2023-08
2. Risk factors for the development of endometrial lesions in breast cancer patients using tamoxyphen: a retrospective cohort study;Revista do Colégio Brasileiro de Cirurgiões;2023
3. Estudo de coorte retrospectivo para avaliação de fatores de risco para desenvolvimento de lesão endometrial em pacientes com câncer da mama em uso de tamoxifeno;Revista do Colégio Brasileiro de Cirurgiões;2023
4. Comparison of aspirating pipettes and hysteroscopy with curettage;Archives of Gynecology and Obstetrics;2020-04-29
5. Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) – Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer;Geburtshilfe und Frauenheilkunde;2018-10